More on CAMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+59.7% Growth)
- Ratings (6.7 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/13/26)
- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CAMP4 Therapeutics (NQ:CAMP)
Delayed: 4.09 -0.1 (2.39%)
Prev. Close $4.19  
Open$4.19 
52 Wk High$21.34 
52 Wk Low$12.13 
Day High$4.24 
Day Low$4.01 
P/E 3.08  
EPS$1.33 
Volume22,325 

Friends, Peers and Foes (?): A68, STH, LTRX, RFIL, SQNS (more...)

Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Schwab Andrew J.
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: WILLIAMS DOUGLAS E
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Young Richard A
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Holtzman Steven H
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Stewart Murray
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Nashat Amir
Jun 10, 2026 04:54 AM Chardan Starts CAMP4 Therapeutics Corp (CAMP) at Buy
May 21, 2026 04:05 PM CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2026 07:00 AM CAMP4 Therapeutics reports seizure improvements in preclinical study
May 14, 2026 07:00 AM CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
View All Articles

Entities mentioned with CAMP

View All Entities